JM

John Mckearn

Venture Capital / BioPharma R&D

United States

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $1,000,000.00

Skills

Biotechnology
Life Sciences
Pharmaceuticals
Drug Discovery
Immunology
Drug Development
Lifesciences
Pharmaceutical Industry
Medicinal Chemistry
Clinical Development
Genomics
Oncology
Technology Transfer
Biopharmaceuticals
Patents

Education

Lists including John

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

OncoResponse

Series D

Total Funding: $110M

Bonum Therapeutics

Series A

Total Funding: $93M

Good Therapeutics

Series B

Total Funding: $30M

Wugen

Series B

Total Funding: $170M

Allakos

Series A

Total Funding: $290M

Arch Oncology

Series A

Total Funding: $86M

Otonomy

Series B

Total Funding: $180M

ZS Pharma

Series C

Total Funding: $100M

Lumena Pharmaceuticals

Series A

Total Funding: $68M

Work Experience

RiverVest Venture Partners

2008

  • Managing Director

    2008

PennyHead LLC

2004

  • President

    2004

    Life Sciences / BioPharmaceutical Consulting

IP
IDM Pharma

2000 - 2009

  • Board Member

    2000 - 2009

Kalypsys

2003 - 2006

  • CSO, President & CEO

    2003 - 2006

P
Pharmacia

2000 - 2003

  • Sr VP of Discovery Research

    2000 - 2003

Searle

1987 - 2000

  • Research

    1987 - 2000